Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide with or without CPAP in adults with type 2 diabetes mellitus and obstructive sleep apnoea
ISRCTN16250774Phase 4Completed
- Sponsor
- University of Liverpool
- Start
- Sep 2015
- Modality
- Peptides
01
Overview
Phase 4, randomised, open-label trial of liraglutide in type 2 diabetes mellitus (T2DM) and obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by University of Liverpool. Started Sep 2015; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ISRCTN16250774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16250774.